The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
17β-Estradiol Reduces Stroke Injury in Estrogen-Deficient Female Animals
Open accessAbstract
Background and Purpose —The importance of postmenopausal estrogen replacement therapy for stroke in females remains controversial. We previously showed that female rats sustain less infarction in reversible middle cerebral artery occlusion (MCAO) than their ovariectomized counterparts and that vascular mechanisms are partly responsible for improved tissue outcomes. Furthermore, exogenous estrogen strongly protects the male brain, even when administered in a single injection before MCAO injection. The present study examined the hypothesis that replacement of 17β-estradiol to physiological levels improves stroke outcome in ovariectomized, estrogen-deficient female rats, acting through blood flow–mediated mechanisms. Methods —Age-matched, adult female Wistar rats were ovariectomized and treated with 0, 25, or 100 μg of 17β-estradiol administered through a subcutaneous implant or with a single Premarin (USP) injection (1 mg/kg) given immediately before ischemia was induced (n=10 per group). Each animal subsequently underwent 2 hours of MCAO by the intraluminal filament technique, followed by 22 hours of reperfusion. Ipsilateral parietal cortex perfusion was monitored by laser-Doppler flowmetry throughout ischemia. Cortical and caudate-putamen infarction volumes were determined by 2,3,5-triphenyltetrazolium chloride staining and digital image analysis. End-ischemic regional cerebral blood flow was measured in ovariectomized females with 0- or 25-μg implants (n=4 per group) by 14 C-iodoantipyrine quantitative autoradiography. Results —Plasma estradiol levels were 3.0±0.6, 20±8, and 46±10 pg/mL in the 0-, 25-, and 100-μg groups, respectively. Caudate-putamen infarction (% of ipsilateral caudate-putamen) was reduced by long-term, 25-μg estrogen treatment (13±4% versus 31±6% in the 0-μg group, P <0.05, and 22±3% in the 100-μg group). Similarly, cortical infarction (% of ipsilateral cortex) was reduced only in the 25-μg group (3±2% versus 12±3% in the 0-μg group, P <0.05, and 6±3% in the 100-μg group. End-ischemic striatal or cortical blood flow was not altered by estrogen treatment at the neuroprotective dose. Infarction volume was unchanged by acute treatment before MCAO when estrogen-treated animals were compared with saline vehicle–treated animals. Conclusions —Long-term estradiol replacement within a low physiological range ameliorates ischemic brain injury in previously ovariectomized female rats. The neuroprotective mechanism is flow-independent, not through preservation of residual ischemic regional cerebral blood flow. Furthermore, the therapeutic range is narrow, because the benefit of estrogen in transient vascular occlusion is diminished at larger doses, which yield high, but still physiologically relevant, plasma 17β-estradiol levels. Lastly, unlike in the male brain, single-injection estrogen exposure does not salvage ischemic tissue in the female brain. Therefore, although exogenous steroid therapy protects both male and female estrogen-deficient brain, the mechanism may not be identical and depends on long-term hormone augmentation in the female.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reversible middle cerebral artery occlusion without craniectomy in rats.
Longa, E. Z., Weinstein, P. R., Carlson, S., & Cummins, R. (1989) · Stroke · doi:10.1161/01.str.20.1.84 · Cited by 7,463
Kuiper, G. G. J. M., Carlsson, B., Grandien, K., Enmark, E., Häggblad, J., Nilsson, S., & Gustafsson, J.-A. (1997) · Endocrinology · doi:10.1210/endo.138.3.4979 · Cited by 4,442
ERβ: Identification and characterization of a novel human estrogen receptor
Mosselman, S., Polman, J., & Dijkema, R. (1996) · FEBS Letters · doi:10.1016/0014-5793(96)00782-x · Cited by 2,269
Simerly, R. B., Swanson, L. W., Chang, C., & Muramatsu, M. (1990) · Journal of Comparative Neurology · doi:10.1002/cne.902940107 · Cited by 2,118
BUTCHER, R. L., COLLINS, W. E., & FUGO, N. W. (1974) · Endocrinology · doi:10.1210/endo-94-6-1704 · Cited by 1,308
Postmenopausal Hormone Therapy and Mortality
Grodstein, F., Stampfer, M. J., Colditz, G. A., Willett, W. C., Manson, J. E., Joffe, M., Rosner, B., Fuchs, C., Hankinson, S. E., Hunter, D. J., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199706193362501 · Cited by 1,184
Woolley, C., & McEwen, B. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-07-02549.1992 · Cited by 990
Measurement of local cerebral blood flow with iodo [14C] antipyrine
Sakurada, O., Kennedy, C., Jehle, J., Brown, J. D., Carbin, G. L., & Sokoloff, L. (1978) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1978.234.1.h59 · Cited by 926
Cardiovascular Health and Disease in Women
Wenger, N. K., Speroff, L., & Packard, B. (1993) · New England Journal of Medicine · doi:10.1056/nejm199307223290406 · Cited by 801
Gender-Linked Brain Injury in Experimental Stroke
Alkayed, N. J., Harukuni, I., Kimes, A. S., London, E. D., Traystman, R. J., & Hurn, P. D. (1998) · Stroke · doi:10.1161/01.str.29.1.159 · Cited by 753
Self-citation
Cited by
Garcia-Segura, L. M., Azcoitia, I., & DonCarlos, L. L. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00025-3 · Cited by 938
ROOF, R. L., & HALL, E. D. (2000) · Journal of Neurotrauma · doi:10.1089/neu.2000.17.367 · Cited by 655
Neurotrophic and neuroprotective actions of estrogen: Basic mechanisms and clinical implications
Brann, D. W., Dhandapani, K., Wakade, C., Mahesh, V. B., & Khan, M. M. (2007) · Steroids · doi:10.1016/j.steroids.2007.02.003 · Cited by 647
Estrogen receptor α, not β, is a critical link in estradiol-mediated protection against brain injury
Dubal, D. B., Zhu, H., Yu, J., Rau, S. W., Shughrue, P. J., Merchenthaler, I., Kindy, M. S., & Wise, P. M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.4.1952 · Cited by 547
Influence of sex steroid hormones on cerebrovascular function
Krause, D. N., Duckles, S. P., & Pelligrino, D. A. (2006) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01095.2005 · Cited by 431
Estrogen as a Neuroprotectant in Stroke
Hurn, P. D., & Macrae, I. M. (2000) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200004000-00001 · Cited by 401
Self-citationNeuroprotective Function of the PGE2EP2 Receptor in Cerebral Ischemia
McCullough, L., Wu, L., Haughey, N., Liang, X., Hand, T., Wang, Q., Breyer, R. M., & Andreasson, K. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.4485-03.2004 · Cited by 361
Brain damage, sex hormones and recovery: a new role for progesterone and estrogen?
Stein, D. G. (2001) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01821-x · Cited by 340
Neuroprotective Effects of Female Gonadal Steroids in Reproductively Senescent Female Rats
Alkayed, N. J., Murphy, S. J., Traystman, R. J., & Hurn, P. D. (2000) · Stroke · doi:10.1161/01.str.31.1.161 · Cited by 333
Self-citationEstrogen and ischemic neuroprotection: an integrated view
McCullough, L. D., & Hurn, P. D. (2003) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(03)00076-6 · Cited by 317
Self-citationLong-term prognosis and causes of death in CADASIL: a retrospective study in 411 patients
Opherk, C. (2004) · Brain · doi:10.1093/brain/awh282 · Cited by 313
Li, X., Blizzard, K. K., Zeng, Z., DeVries, A. C., Hurn, P. D., & McCullough, L. D. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2004.01.004 · Cited by 303
Self-citationde la Torre, J. C. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00111-1 · Cited by 284
Jover, T., Tanaka, H., Calderone, A., Oguro, K., Bennett, M. V. L., Etgen, A. M., & Zukin, R. S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-06-02115.2002 · Cited by 282
Tanapat, P., Hastings, N. B., & Gould, E. (2005) · Journal of Comparative Neurology · doi:10.1002/cne.20385 · Cited by 273
Turgeon, J. L., Carr, M. C., Maki, P. M., Mendelsohn, M. E., & Wise, P. M. (2006) · Endocrine Reviews · doi:10.1210/er.2005-0020 · Cited by 264
Jung, J. E., Kim, G. S., Chen, H., Maier, C. M., Narasimhan, P., Song, Y. S., Niizuma, K., Katsu, M., Okami, N., Yoshioka, H., et al. (2010) · Molecular Neurobiology · doi:10.1007/s12035-010-8102-z · Cited by 256
McCarthy, M., & Raval, A. P. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01998-9 · Cited by 254
An antagomir to microRNA Let7f promotes neuroprotection in an ischemic stroke model
Selvamani, A., Sathyan, P., Miranda, R. C., & Sohrabji, F. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032662 · Cited by 217
Bramlett, H. M., & Dietrich, W. D. (2001) · Journal of Neurotrauma · doi:10.1089/089771501750451811 · Cited by 213
O'Donnell, M. E., Lam, T. I., Tran, L. Q., Foroutan, S., & Anderson, S. E. (2006) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600278 · Cited by 107
Wilson, M. E., Westberry, J. M., & Trout, A. L. (2011) · Hormones and Behavior · doi:10.1016/j.yhbeh.2010.08.004 · Cited by 85
Stary, C. M., Xu, L., Li, L., Sun, X., Ouyang, Y.-B., Xiong, X., Zhao, J., & Giffard, R. G. (2017) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2017.05.004 · Cited by 49
“This effect is in part reversed by exogenous replacement of 17β-estradiol (E2, Dubal et al., 1998; Rusa et al., 1999) improving sensorimotor and spatial memory deficits in ovariectomized females (Li et al.”
Metadata
- Authors
- Rusa, R., Alkayed, N. J., Crain, B. J., Traystman, R. J., Kimes, A. S., London, E. D., Klaus, J. A., & Hurn, P. D.
- Venue
- Stroke
- Published
- 1999-08
- Volume
- 30
- Issue
- 8
- Pages
- 1665-1670
- ISSN
- 0039-2499 (ISSN-L)
- 1524-4628
- OpenAlex
- W1862183284
- Cited by
- 304
- References
- 37
- FWCI
- 10.47
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.